NDC 0409-2337

Deferoxamine Mesylate

Deferoxamine Mesylate

Deferoxamine Mesylate is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Deferoxamine Mesylate.

Product ID0409-2337_1eaf1059-bb03-4263-9b7d-9ce0f4a8ebb8
NDC0409-2337
Product TypeHuman Prescription Drug
Proprietary NameDeferoxamine Mesylate
Generic NameDeferoxamine Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2005-03-31
Marketing CategoryANDA / ANDA
Application NumberANDA076019
Labeler NameHospira, Inc.
Substance NameDEFEROXAMINE MESYLATE
Active Ingredient Strength2 g/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0409-2337-25

4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15)
Marketing Start Date2005-03-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-2337-12 [00409233712]

Deferoxamine Mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA076019
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-03-17
Marketing End Date2004-03-17

NDC 0409-2337-25 [00409233725]

Deferoxamine Mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA076019
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-03-31

NDC 0409-2337-15 [00409233715]

Deferoxamine Mesylate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA076019
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-13

Drug Details

Active Ingredients

IngredientStrength
DEFEROXAMINE MESYLATE2 g/1

OpenFDA Data

SPL SET ID:f9ab6b1c-98d0-4373-0e9b-b10cb4a67543
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1731345
  • 1731350
  • Pharmacological Class

    • Iron Chelating Activity [MoA]
    • Iron Chelator [EPC]
    • Iron Chelating Activity [MoA]
    • Iron Chelator [EPC]

    NDC Crossover Matching brand name "Deferoxamine Mesylate" or generic name "Deferoxamine Mesylate"

    NDCBrand NameGeneric Name
    0409-2336Deferoxamine MesylateDeferoxamine Mesylate
    0409-2337Deferoxamine MesylateDeferoxamine Mesylate
    47781-623Deferoxamine mesylateDeferoxamine mesylate
    47781-624Deferoxamine mesylateDeferoxamine mesylate
    52609-4504Deferoxamine mesylateDeferoxamine mesylate
    52609-4505Deferoxamine mesylateDeferoxamine mesylate
    60505-6236Deferoxamine mesylateDeferoxamine mesylate
    60505-6237Deferoxamine mesylateDeferoxamine mesylate
    60505-6238Deferoxamine mesylateDeferoxamine mesylate
    68083-172Deferoxamine mesylateDeferoxamine mesylate
    68083-173Deferoxamine mesylateDeferoxamine mesylate
    63323-597DeferoxamineDEFEROXAMINE MESYLATE
    63323-599DeferoxamineDEFEROXAMINE MESYLATE
    0078-0467Desferaldeferoxamine mesylate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.